India to Malta: Everolimus Export Trade Route
India has recorded 45 verified shipments of Everolimus exported to Malta, representing a combined trade value of $3.9M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $87.4K USD. The leading Indian exporter is NATCO PHARMA LIMITED, which accounts for 81% of total export value with 37 shipments worth $3.2M USD. On the buying side, PHARMACARE PREMIUM is the largest importer in Malta with $3.2M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Malta Everolimus corridor is one of India's established pharmaceutical export routes, with 45 shipments documented worth a combined $3.9M USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 81% of all export value, reflecting the consolidated nature of India's everolimus manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $87.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with everolimus's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 19.3%, placing it at rank #9 among India's top everolimus export destinations globally.
On the import side, key buyers of Indian everolimus in Malta include PHARMACARE PREMIUM, PHARMACARE PREMIUM . PHARMACARE PREMIUM is the single largest importer with 37 shipments valued at $3.2M USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#9
- Annual growth+19.3%
- Demand growth+18.4%
- Regulatory ease76/100
Top 10 Indian Everolimus Exporters to Malta
Showing top 10 of 2 Indian suppliers exporting Everolimus to Malta, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED Avg $86.3K per shipment | 37 | $3.2M | 81.2% |
| 2 | NATCO PHARMA LIMITED Avg $92.3K per shipment | 8 | $738.5K | 18.8% |
This table shows the top 10 of 2 Indian companies exporting everolimus to Malta, ranked by total trade value. The listed exporters are: NATCO PHARMA LIMITED, NATCO PHARMA LIMITED . NATCO PHARMA LIMITED is the dominant supplier with 37 shipments worth $3.2M USD, giving it a 81% market share.
Top 10 Everolimus Importers in Malta
Showing top 10 of 2 known buyers in Malta receiving Everolimus shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian everolimus in Malta include PHARMACARE PREMIUM, PHARMACARE PREMIUM . The largest importer is PHARMACARE PREMIUM, accounting for $3.2M USD across 37 shipments — representing 81% of all everolimus imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACARE PREMIUM | 37 | $3.2M | 81.2% |
| 2 | PHARMACARE PREMIUM | 8 | $738.5K | 18.8% |
Top 10 Everolimus Formulations Imported by Malta
Showing top 10 of 36 product formulations shipped on the India to Malta Everolimus route, ranked by trade value
Malta imports a wide range of everolimus formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — EVEROLIMUS 10 MG TABLETS (BULK) (APPENDIX 4R RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:124045) — accounts for $311.7K USD across 1 shipments. There are 36 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVEROLIMUS 10 MG TABLETS (BULK) (APPENDIX 4R RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:124045) | 1 | $311.7K | 7.9% |
| 2 | EVEROLIMUS TABELTS 10 MG (BULK) (OTHER R | 1 | $257.3K | 6.5% |
| 3 | EVEROLIMUS TABLETS 10 MG (BULK) (OTHER REFERENCE CI NO:124002)(RODTEP ENTRY NO:10112) | 3 | $247.9K | 6.3% |
| 4 | EVEROLIMUS TABLETS 10 MG (BULK) | 1 | $231.2K | 5.9% |
| 5 | EVEROLIMUS 10 MG TABLETS (BULK) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REFERENCE(S) CI NO:124242) | 1 | $226.1K | 5.8% |
| 6 | EVEROLIMUS TABLETS 5 MG (BULK) (OTHER RE | 2 | $222.6K | 5.7% |
| 7 | EVEROLIMUS 10 MG TABLETS (BULK) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REFERENCE(S) CI NO:125024) | 1 | $190.0K | 4.8% |
| 8 | EVEROLIMUS TABLETS 10 MG BULK OTHER REF CI NO.123176 RODTEP ENTRY NO 10112 | 1 | $185.8K | 4.7% |
| 9 | EVEROLIMUS TABLETS 10 MG (BULK)(OTHER REFERENCE CI NO: 123255)(RODTEP ENTRY NO:10112)NOS | 3 | $185.4K | 4.7% |
| 10 | EVEROLIMUS TABLETS 10 MG (BULK) (OTHER R | 1 | $180.5K | 4.6% |
Showing top 10 of 36 Everolimus formulations imported by Malta on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 17 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's everolimus exports to Malta are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 37 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Malta benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NATCO PHARMA LIMITED, NATCO PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $87.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as everolimus tabelts 10 mg (bulk) (other r and everolimus tablets 10 mg (bulk) (other reference ci no:124002)(rodtep entry no:10112), suggesting that buyers in Malta tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PHARMACARE PREMIUM is the largest importer with 37 shipments worth $3.2M USD — representing 81% of all everolimus imports from India on this route.
Route Statistics
- Trade Volume
- $3.9M
- Avg. Shipment
- $87.4K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~19 days
- Annual Growth
- +19.3%
Related Analysis
Reverse Direction
Malta → India — Everolimus (Import)Other Everolimus Routes
Unlock the Full India to Malta Everolimus Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 45 shipments on this route.
Frequently Asked Questions — India to Malta Everolimus Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Everolimus to Malta?
The leading Indian exporters of Everolimus to Malta are NATCO PHARMA LIMITED, NATCO PHARMA LIMITED . NATCO PHARMA LIMITED holds the largest market share at approximately 81% of total trade value on this route.
Q What is the total value of Everolimus exports from India to Malta?
India exports Everolimus to Malta worth approximately $3.9M USD across 45 recorded shipments. The average value per shipment is $87.4K USD.
Q Which ports does India use to ship Everolimus to Malta?
The most active port of origin is HYDERABAD ACC (INHYD4) with 17 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Malta for Everolimus?
The average transit time for Everolimus shipments from India to Malta is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Malta Everolimus trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.3% with demand growth tracking at 18.4%. The route is ranked #9 among India's top Everolimus export destinations globally.
Q How many suppliers are active on the India to Malta Everolimus route?
There are currently 2 active Indian suppliers exporting Everolimus to Malta. The market is moderately concentrated with NATCO PHARMA LIMITED accounting for 81% of total shipment value.
Q Who are the main importers of Everolimus from India in Malta?
The leading importers of Indian Everolimus in Malta include PHARMACARE PREMIUM, PHARMACARE PREMIUM . PHARMACARE PREMIUM is the largest buyer with 37 shipments worth $3.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Malta export trade corridor identified from Indian Customs (DGFT) records for Everolimus.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Malta matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 45 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
45 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists